期刊文献+

阿托伐他汀治疗高血压患者动脉粥样硬化 被引量:23

Chinical Study of Effect of Atorvastatin on Atherosclerosis of Patients with Hypertension
下载PDF
导出
摘要 目的研究阿托伐他汀对颈动脉粥样硬化斑块的影响。方法用阿托伐他汀10mg每日一次口服,服药前后做颈动脉超声检查记录斑块体积和性质、C反应蛋白(C-reactive prote in,CRP)、总胆固醇(TC)、甘油三酯(TG)、高密度脂蛋白胆固醇(HDL)、低密度脂蛋白胆固醇(LDL)的变化。结果治疗6个月后,患者颈动脉粥样硬化斑块厚度明显减少,TC、TG、CRP均明显下降,与对照组相比,有显著统计学差异。结论抗高血压联合阿托伐他汀调脂治疗对高血压病患者颈动脉粥样硬化斑块有稳定作用。 Objective To study the influence of atorvastatin on the atherosclerosis plaque of carotid artery. Methods Eighty - two patients were treated with 10mg atovastatin one time per day for 6 months. The atherosclerosis plaque volume and character of carotid artery were measured before and after treatment in all patients with Doppler uhrasonograph. The levels of C -reactive protein (CRP) , total cholesterol ( TC ), triglyeeride ( TG), high density lipoprotein cholesterol ( HDL - C ) and low density lipoprotein cholesterol (LDL - C) were also assayed at the onset and the end of the study. Results After 6 months administration of atovastatin, the thickness of the atheroselerosis plaque of carotid artery reduced significantly,the levels of TC,TG and CRP were all reduced. Comparing with the control group, the differences were significant statisticaly. Conclusion The treatment of atorvastatin modulating blood lipid combined with antihypertension can stabilize the plaque of carotid artery of patients with hypertension.
出处 《医药论坛杂志》 2006年第8期17-18,共2页 Journal of Medical Forum
基金 河南省科技厅重点科技攻关项目 项目编号0323030800
关键词 阿托伐他汀 动脉粥样硬化 高血压 治疗 Atorvastatin Atheroselerosis Hypertension Treatment
  • 相关文献

参考文献8

  • 1Grundy SM,Clemen JI,Mers CN,et al.Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel Ⅲ guideline,Circulation,2004,110(2):227
  • 2Cannon CP,Braunwald E,McCabe CH,et al.Intensive versus Moderate lipid lowering with statins after acute coronary sysdromes.N Engl Med,2004,350(15):1495
  • 3Shepherd J,Blauw GJ,Murphy MB,et al.Pravastatin in elderly individuals at risk of vascular disease:a randomized controlled trial.Lancet,2002,360:1623
  • 4Pearson TA,Mensah GA,Alexander RW,et al.Markers of Inflammation and Cardiovascular Disease:Application to Clinical and Public Health Practice:A Statement for Healthcare Professionals From the Centers for Disease Control and Prevention and the American Heart Association.Circulation,2003,107:499-511
  • 5Roivainen M,Kajander MV,Palosuo P,et al.Infections,Inflammation,and the Risk of Coronary Heart Disease.Circulation,2000,101:252
  • 6Downs JR,Clearfield M,Whitney E,et al.Primarg prevention of acute coronary events with lovastatin in men and womem with average choresterol levels.JAMA,1998:1615-1622
  • 7Ridker PM,Buring JE,Shih J,et al.Prospective Study of C -Reactive Protein and the Risk of Future Cardiovascular Events Among Apparently Healthy Women.Circulation,1998,98:731
  • 8Crisby M,Fredriksson GN,Shah PK,et al.Pravastatin Treatment Increases Collagen Content and Decreases Lipid Content,Inflammation,Metalloproteinases,and Cell Death in Human Carotid Plaques:Implications for Plaque Stabilization.Circulation,2001,103:926

同被引文献144

引证文献23

二级引证文献140

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部